ArticleThe Journal of urology2017
Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria.
Dean G AssimosPubMed ↗Publisher ↗
No numbers read from the abstract.